BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3140079)

  • 1. Progressive IgA nephropathy: the role of hypertension.
    Payton CD; McLay A; Jones JM
    Nephrol Dial Transplant; 1988; 3(2):138-42. PubMed ID: 3140079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgA nephropathy: the presence of familial disease does not confer an increased risk for progression.
    Izzi C; Ravani P; Torres D; Prati E; Viola BF; Guerini S; Foramitti M; Frascà G; Amoroso A; Ghiggeri GM; Schena FP; Scolari F
    Am J Kidney Dis; 2006 May; 47(5):761-9. PubMed ID: 16632014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presentation, prognosis and outcome of IgA nephropathy in Indian adults.
    Chacko B; John GT; Neelakantan N; Korula A; Balakrishnan N; Kirubakaran MG; Jacob CK
    Nephrology (Carlton); 2005 Oct; 10(5):496-503. PubMed ID: 16221102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy.
    Komatsu H; Fujimoto S; Hara S; Sato Y; Yamada K; Eto T; Nakao H
    Ren Fail; 2005; 27(1):45-52. PubMed ID: 15717634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary IgA nephropathy: natural history and factors of importance in the progression of renal impairment.
    Ibels LS; Gyory AZ; Caterson RJ; Pollock CA; Mahony JF; Waugh DA; Roger SD; Coulshed S
    Kidney Int Suppl; 1997 Oct; 61():S67-70. PubMed ID: 9328970
    [No Abstract]   [Full Text] [Related]  

  • 7. [The survival of patients with mesangial immunoglobulin A glomerulonephritis].
    Belovezhdov N; Robeva R; Dimitrova V
    Vutr Boles; 1990; 29(4):40-7. PubMed ID: 2281658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.
    Espinosa M; Ortega R; Gómez-Carrasco JM; López-Rubio F; López-Andreu M; López-Oliva MO; Aljama P
    Nephrol Dial Transplant; 2009 Mar; 24(3):886-91. PubMed ID: 18842673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in immunoglobulin-A nephropathy.
    Muthukumar T; Fernando ME; Jayakumar M
    J Assoc Physicians India; 2002 Nov; 50():1354-9. PubMed ID: 12583461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predicting progression of IgA nephropathies.
    Coppo R; D'Amico G
    J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification of patients with IgA nephropathy.
    Barbour SJ; Reich HN
    Am J Kidney Dis; 2012 Jun; 59(6):865-73. PubMed ID: 22497792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of sex in primary glomerulonephritis.
    Cattran DC; Reich HN; Beanlands HJ; Miller JA; Scholey JW; Troyanov S;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up.
    Kanno Y; Okada H; Saruta T; Suzuki H
    Clin Nephrol; 2000 Nov; 54(5):360-5. PubMed ID: 11105796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of IgA nephropathy in patients followed-up for more than ten years in Spain.
    Velo M; Lozano L; Egido J; Gutierrez-Millet V; Hernando L
    Semin Nephrol; 1987 Dec; 7(4):346-50. PubMed ID: 3445013
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary IgA nephropathy in adults.
    George J; Ninan VT; Thomas PP; Jacob CK; Shastry JC
    J Assoc Physicians India; 1993 Aug; 41(8):489-91. PubMed ID: 8294350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can immunosuppressive drugs slow the progression of IgA nephropathy?
    Goumenos D; Ahuja M; Shortland JR; Brown CB
    Nephrol Dial Transplant; 1995; 10(7):1173-81. PubMed ID: 7478120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasculitic IgA nephropathy: prognosis and outcome.
    Pankhurst T; Lepenies J; Nightingale P; Howie AJ; Adu D; Harper L
    Nephron Clin Pract; 2009; 112(1):c16-24. PubMed ID: 19342865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrotic range proteinuria--a good predictive index of disease in IgA nephropathy?
    Lai KN; Ho CP; Chan KW; Yan KW; Lai FM; Vallance-Owen J
    Q J Med; 1985 Oct; 57(222):677-88. PubMed ID: 4080957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant or accelerated hypertension in IgA nephropathy.
    Subías R; Botey A; Darnell A; Montoliu J; Revert L
    Clin Nephrol; 1987 Jan; 27(1):1-7. PubMed ID: 3815903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and natural history of IgA nephropathy.
    Rychlik I; Andrassy K; Waldherr R; Zuna I; Tesar V; Jancová E; Stejskalová A; Ritz E
    Ann Med Interne (Paris); 1999 Feb; 150(2):117-26. PubMed ID: 10392260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.